ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,304.80
      2.37%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.045
      -0.37%
      Bitcoin
      63,849.63
      1.43%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sage Therapeutics Inc (SAGE)

      7. Sage Therapeutics Inc (SAGE) Financials

      Sage Therapeutics Inc

      Sage Therapeutics Inc (SAGE)

      Sage Potash Corp
      7.90
      0.31
      (4.08%)
      Closed September 20 4:00PM
      Delayed by 15 minutes
      7.90
      -0.01
      (-0.13%)
      After Hours: 7:08PM
      Delayed by 15 minutes

      Sage Therapeutics Inc Financial Summary

      The current SAGE market cap is 482.3M. The company's latest EPS is USD -8.8695 and P/E is -0.89.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.47M2.72M77.97M7.9M8.65M
      Operating Income -170.46M-211.85M-42.07M-117.68M-111.3M
      Net Income -160.33M-201.63M-32.71M-108.48M-102.85M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.87M1.11B6.31M7.69M86.46M
      Operating Income -708.12M596.23M-460.91M-546.99M-579.85M
      Net Income -680.24M606.07M-457.89M-532.78M-541.49M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.08B949.66M882.28M767.6M697.11M
      Total Liabilities 97.91M133M82.75M61.8M69.04M
      Total Equity 984.38M816.66M799.53M705.8M628.06M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.08B2.16B1.83B1.36B882.28M
      Total Liabilities 139.5M86.91M96.26M103.85M82.75M
      Total Equity 944.66M2.07B1.73B1.25B799.53M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -285.2M-421.07M-540.59M-37.83M-118.27M
      Investing 240.46M400.85M442.91M139.44M139.05M
      Financing 3.52M6.29M6.03M1.56M9.63M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -528.71M664.28M-378.18M-460.04M-540.59M
      Investing -143.16M442.68M-1B325.43M442.91M
      Financing 607.62M426.76M13.33M3.07M6.03M

      Stats and Ratios

      Market Cap 482.3M
      Price to Earnings Ratio -0.89
      Price to Sales Ratio 5.59
      Price to Cash Ratio 6.8
      Price to Book Ratio 0.6
      Dividend Yield -

      Share Statistics

      Shares Outstanding 61.05M
      Average Volume (1 week) 486.7k
      Average Volume (1 Month) 585.73k
      52 Week Change -61.43%
      52 Week High 28.26
      52 Week Low 7.19
      Spread (Intraday) 1.05 (11.73%)

      Company Info

      Company Name Sage Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.sagerx.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      SAGE
      Sage Therapeutics
      Delayed Upgrade Clock